Novo Nordisk
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.About NVO
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments.
NVO Key Statistics
Stock Snapshot
With a market cap of 209.84B, Novo Nordisk(NVO) trades at $47.95. The stock has a price-to-earnings ratio of 13.84 and currently yields dividends of 2.6%.
On 2025-11-21, Novo Nordisk(NVO) stock moved within a range of $46.69 to $48.15. With shares now at $47.95, the stock is trading +2.7% above its intraday low and -0.4% below the session's peak.
Trading activity shows a volume of 15.85M, compared to an average daily volume of 18.06M.
Over the past 52 weeks, Novo Nordisk(NVO) stock has traded between a high of $112.52 and a low of $45.05.
Over the past 52 weeks, Novo Nordisk(NVO) stock has traded between a high of $112.52 and a low of $45.05.
NVO News
Lilly is crossing $1 trillion in market cap just as Wall Street is getting jittery over a potential AI bubble. Eli Lilly, propelled by sales of its blockbuster...
Shares of Danish pharmaceutical Novo Nordisk (NVO) traded flat on Friday afternoon after its key U.S.-based rival Eli Lilly (LLY) reached $1 trillion in market...
Danish drugmaker Novo Nordisk A/S was at the forefront of the weight-loss injection boom as people discovered that its Ozempic shot, originally developed to tre...
Analyst ratings
59%
of 32 ratingsMore NVO News
Upcoming data from Novo Nordisk A/S (NYSE:NVO) early next month could offer the clearest signal yet on whether GLP-1 medicines — widely used for diabetes and we...
Millions of people in the world are overweight, and Novo Nordisk hopes to capture a growing share of this lucrative treatment opportunity. Novo Nordisk (NVO 1....
Novo Nordisk (NYSE: NVO) has found phenomenal success in treating patients with obesity and diabetes. *Stock prices used were the afternoon prices of Jan. 1, 2...
Wondering if Novo Nordisk’s recent share price swings have created a true value opportunity or a value trap? You’re not alone. A thoughtful look at the numbers...
...
Novo Nordisk just addressed a problem that has prevented some from taking these drugs. Investors generally buy pharmaceutical stocks to add an element of safet...
Denmark is heading for its worst year of job losses since the Covid pandemic, as sweeping cuts at pharmaceutical giant Novo Nordisk A/S drive a surge in redunda...
